AI-driven algorithms can streamline clinical trials by identifying suitable candidates more efficiently and predicting patient responses to new treatments. This can accelerate the development of new cancer therapies and improve the success rates of clinical trials. AI can also monitor patient data in real-time, allowing for adaptive trial designs that can be modified based on interim results.
